VNS is Associated with Low Mortality and Low Use of Mechanical Ventilation in COVID-19 Patients

Share on facebook
Share on twitter
Share on linkedin

Proud to announce the publication of our recent study, “Transcutaneous Vagus Nerve Stimulation is Associated with Lower Mechanical Ventilation and Mortality in COVID-19 Patients“.

Conducted in Buenos Aires, the study demonstrated that using transcutaneous vagus nerve stimulation (taVNS) used 4 times daily in hospitalized patients with COVID-19 was associated with a low requirement for mechanical ventilation and low mortality compared to other hospitalization cohorts.

Transcutaneous vagus nerve stimulation is a potent inhibitor of inflammatory cytokines. Ideal for any hospital setting, taVNS is low cost, safe and a single device can be used among different patients simultaneously. #covid #vns #vagusnerve #NemechekTechnologies

5 1 vote
Article Rating
Patrick Nemechek, D.O.

Patrick Nemechek, D.O.

Notify of
Inline Feedbacks
View all comments

Recent Articles

Follow Us

Subscribe to Dr. Nemechek's YouTube Channel

Is Autonomic Dysfunction Affecting Your Health?

Take the Autonomic Health Quiz

Would love your thoughts, please comment.x
Send this to a friend